Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Opsens Inc T.OPS

Alternate Symbol(s):  OPSSF

OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. The Company supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

RE:Good day!

Definitely Morgan Stanley pumping it up. I would love to know what the strategy is. Last record high was MS buying and they were selling on the way down as well.  rate and reply

Good day!

Anonymous and Morgan Stanley have switched on the Buying side! Better volume than the last weeks and a good increase. Q3 results in 2 -3 weeks. It smells good! GLTA!  rate and reply

We need more positive comments...

 TAVR procedure benefits a larger group of patients and with the minimalist approach growing in popularity within the medical community, the benefits of the SavvyWire could be significant."...read more

RE:RE:Its a marvelous day!

Last this, If I’m not wrong Mr. Villeneuve only Have 25k options to exercise at 1.33.  rate and reply

Top Gainers

Pretty impressive during another tough day in the markets. GLTA Symbol/ Company Price $ Change $ Volume Data delayed at least 15 minutes,...read more

RE:Its a marvelous day!

Robin Villeneuve exercised options without selling any this Week. Robin Villeneuve did many transactions since one month or more. Exercised ar 1.33 And sold on open market right after. But not this...read more

Its a marvelous day!

Hopefully we finish with a bang!  rate and reply

RE:first commercial use Savvywire (TM)

The Fall is shaping up to be transformational for us . GLTA   rate and reply

RE:RE:RE:TAVR procedure potential...

Here's the press release dating back to September 3rd 2015 relating to the corporate restructuring I was referring to in my previous post: https://opsens.com/2015/opsens-announces-a-reorganization...read more

RE:RE:TAVR procedure potential...

Dogs, either you're short and a bit worried so you try to keep the stock down or you didn't do your research properly ...or both. Opsens reorganised in 2015 to seperate physically and...read more

RE:TAVR procedure potential...

Edwards Lifescience per example could be interested in Opsens Medical but couldn't care less about Opsens Solutions which is why I doubt Opsens the company will be a take over target.   rate and reply

TAVR procedure potential...

Opsens to be a take over target not long after FDA approval... The TAVR procedure is on the rise, driven by an aging of the population and recent studies that demonstrate its benefits to patients of...read more

may 7 th $1.74 june 7 $2.26

The last month was very tough for investors but in the same period Opsens is up 30%. In about 5 weeks the results of the third quarter will come out and i  think those will be very good. glta  rate and reply

RE:first commercial use Savvywire (TM)

FDA approval is now expected in the Fall. Initially they had said late Summer or Fall.  rate and reply

first commercial use Savvywire (TM)

Key word - significant ! Timeline reiterated. . As the TAVR procedure benefits a larger group of patients and with the minimalist approach growing in popularity within the medical community, the...read more

New Press Release - OPSENS ANNOUNCES GLOBAL SAVVYWIRE(TM) FIRST COMMERCIAL USE

Dr. Josep Rodés-Cabau at the Quebec Heart and Lung Institute – Laval University and Dr. Réda Ibrahim at The Montreal Heart Institute performed the first utilization simultaneously in Quebec City and MontrealQUEBEC, June 7, 2022 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS...read article.

In the money.

As of today i am in the money l hope im not alone and the stock does not deflate again. Goog luck to all  rate and reply

Morgan Stanley plays its funny game again

As soon as OPS gets some momentum, MS is trying to push it down with 100 shares blocks... I continue to think they try to maintain a reasonable price, waiting for next quarter's results and FDA...read more

Raymond James bangs table for $6 target again

  OpSens is now very undervalued, says Raymond James By Geordie Carragher Published on May 22, 2022 Last Updated on May 22, 2022 Filed under:   All posts, Analysts, Health...read more